Who owns CORCEPT THERAPEUTICS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CORT from SEC Form 13F filings across 503 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 503 institutions disclosed 80.1M shares of CORCEPT THERAPEUTICS INC worth $9.22B — about 75.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
503
13F holders
$9.22B
value, 2026 filers
75.2%
of shares outstanding (80.1M sh)
127
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CORT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.2M | $1.17B | 0.0% | 9.6% | -18.0% |
| 2 | INGALLS & SNYDER LLC | 7.7M | $883.6M | 22.6% | 7.2% | -3.4% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 4.9M | $558.9M | 0.8% | 4.5% | -7.8% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8M | $550.5M | 0.0% | 4.5% | -5.3% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $501.6M | 0.0% | 4.1% | +4.3% |
| 6 | Parallel Advisors, LLC | 3.9M | $449.7M | 6.1% | 3.7% | -1.5% |
| 7 | AQR CAPITAL MANAGEMENT LLC | 3.6M | $419.5M | 0.1% | 3.4% | +41.0% |
| 8 | FMR LLC | 3.5M | $402.0M | 0.0% | 3.3% | +4.5% |
| 9 | STATE STREET CORP | 3.1M | $357.8M | 0.0% | 2.9% | -5.3% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.3M | $269.2M | 0.0% | 2.2% | -7.8% |
| 11 | D. E. Shaw & Co., Inc. | 1.9M | $221.7M | 0.1% | 1.8% | +117.9% |
| 12 | TANG CAPITAL MANAGEMENT LLC | 1.5M | $172.8M | 8.0% | 1.4% | 0.0% |
| 13 | FIRST TRUST ADVISORS LP | 1.4M | $157.7M | 0.1% | 1.3% | -25.2% |
| 14 | UBS Group AG | 1.2M | $136.7M | 0.0% | 1.1% | -13.9% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 964,417 | $111.1M | 0.0% | 0.9% | -26.9% |
| 16 | MORGAN STANLEY | 934,791 | $107.7M | 0.0% | 0.9% | -17.8% |
| 17 | TWO SIGMA INVESTMENTS, LP | 905,678 | $104.4M | 0.1% | 0.8% | +48.5% |
| 18 | NORTHERN TRUST CORP | 877,791 | $101.1M | 0.0% | 0.8% | +16.4% |
| 19 | Cerity Partners LLC | 828,281 | $95.4M | 0.1% | 0.8% | +3.9% |
| 20 | JACOBS LEVY EQUITY MANAGEMENT, INC | 802,458 | $92.5M | 0.3% | 0.8% | +15.4% |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 765,823 | $88.2M | 0.0% | 0.7% | -33.8% |
| 22 | JANE STREET GROUP, LLC | 763,536 | $88.0M | 0.0% | 0.7% | +11715.8% |
| 23 | FULLER & THALER ASSET MANAGEMENT, INC. | 759,176 | $87.5M | 0.3% | 0.7% | +6.9% |
| 24 | EMERALD ADVISERS, LLC | 758,257 | $87.4M | 2.4% | 0.7% | +1.3% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 618,242 | $71.2M | 0.0% | 0.6% | +0.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.